Completed OBSERVATIONAL NCT03413150

Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias (AMIRA)

Sponsor: Groupe Hospitalier Pitie-Salpetriere

Conditions Atrial Fibrillation Atrial Tachycardia

Interventions Amiodarone

Updated 10 times since 2018 Last updated: Sep 24, 2019 Started: Jan 31, 2007 Primary completion: Apr 30, 2012 Completion: Apr 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03413150, this observational or N/A phase trial focuses on Atrial Fibrillation and Atrial Tachycardia and remains completed. Sponsored by Groupe Hospitalier Pitie-Salpetriere, it has been updated 10 times since 2007, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Oct 2019 — Jan 2021 [monthly]

Completed
Nov 2018 — Oct 2019 [monthly]

Completed

▶ Show 5 earlier versions

Oct 2018 — Nov 2018 [monthly]

Completed
Aug 2018 — Oct 2018 [monthly]

Completed
Jun 2018 — Aug 2018 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Feb 2018 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Groupe Hospitalier Pitie-Salpetriere

Data source: Groupe Hospitalier Pitie-Salpetriere

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.